Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Linsitinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 269.00 | 198.00 | 1.3586 | 1.4337 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 257.00 | 198.00 | 1.2980 | 1.3636 |
| MDA-MB-231 | Lapatinib | 1 | uM | 10 | 156.25 | 67.09 | 253.00 | 198.00 | 1.2778 | 1.3400 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 285.00 | 198.00 | 1.4394 | 1.5255 |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 156.25 | 67.09 | 189.00 | 198.00 | 0.9546 | 0.9413 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 265.00 | 198.00 | 1.3384 | 1.4105 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 156.25 | 67.09 | 214.00 | 198.00 | 1.0808 | 1.1021 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 156.25 | 67.09 | 59.00 | 198.00 | 0.2980 | -0.0790 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 156.25 | 67.09 | 206.00 | 198.00 | 1.0404 | 1.0514 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 192.00 | 198.00 | 0.9697 | 0.9610 | |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 156.25 | 67.09 | 118.00 | 198.00 | 0.5960 | 0.4357 |
| MDA-MB-231 | Linsitinib | 19.9526 | uM | 10 | 156.25 | 67.09 | 92.00 | 198.00 | 0.4647 | 0.2241 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 187.00 | 198.00 | 0.9444 | 0.9281 |
| MDA-MB-231 | 17-AAG | 0.0033113 | uM | 10 | 156.25 | 67.09 | 210.00 | 198.00 | 1.0606 | 1.0768 |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 232.00 | 198.00 | 1.1717 | 1.2137 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 223.00 | 198.00 | 1.1263 | 1.1583 | |
| MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 166.00 | 198.00 | 0.8384 | 0.7865 | |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 156.25 | 67.09 | 382.00 | 198.00 | 1.9293 | 2.0467 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 156.25 | 67.09 | 184.00 | 198.00 | 0.9293 | 0.9082 |
| MDA-MB-231 | 17-AAG | 0.1 | uM | 10 | 156.25 | 67.09 | 224.00 | 198.00 | 1.1313 | 1.1645 |
| MDA-MB-231 | Erlotinib | 0.031623 | uM | 10 | 156.25 | 67.09 | 324.00 | 198.00 | 1.6364 | 1.7417 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 156.25 | 67.09 | 279.00 | 198.00 | 1.4091 | 1.4913 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 164.00 | 198.00 | 0.8283 | 0.7727 |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 268.00 | 198.00 | 1.3535 | 1.4279 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 156.25 | 67.09 | 303.00 | 198.00 | 1.5303 | 1.6265 |